Calidi Biotherapeutics Inc. – Filings and Transcripts

NYSE American: CLDI
Share price (8/21/26): $1.34
Market cap (8/21/26): $3.463 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Addition of securities to prior shelf registration

Prospectus supplement with pricing info

Initial registration of new securities

Ownership Filter

Stewart Alan R.

Jackson Andrew C.

Schoeneck James A

News Filter

Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Material Modification to Rights of Security Holders, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Material Definitive Agreement, Termination of Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors

Shareholder Vote Results

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Notice of effectiveness

Correspondence with the SEC